TWD
VNDA icon

True Wealth Design’s Vanda Pharmaceuticals VNDA Stock Holding History

True Wealth Design’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.12K Buy
1,327
+602
+83% +$3.93K ﹤0.01% 1146
2026
Q1 		$5.01K Buy
725
+206
+40% +$1.59K ﹤0.01% 1206
2025
Q4 		$4.58K Sell
519
-11
-2% -$61 ﹤0.01% 1120
2025
Q3 		$2.65K Buy
530
+102
+24% +$472 ﹤0.01% 1368
2025
Q2 		$2.02K Buy
428
+420
+5,250% +$1.84K ﹤0.01% 1182
2025
Q1 		$37 Sell
8
-17
-68% -$79 ﹤0.01% 2462
2024
Q4 		$120 Buy
+25
New +$120 ﹤0.01% 1269

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

True Wealth Design's VNDA Position: Q2 2026 in Review

True Wealth Design increased its Vanda Pharmaceuticals (VNDA) stake by 83% in Q2 2026, buying an estimated $3.93K and bringing the position to 1,327 shares worth $8.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1146.

True Wealth Design first reported a position in VNDA in Q4 2024 and has held it in 7 quarters since. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • True Wealth Design held 1,327 shares of Vanda Pharmaceuticals worth $8.12K as of Q2 2026.
  • True Wealth Design bought 602 Vanda Pharmaceuticals shares in Q2 2026, an estimated $3.93K.
  • Vanda Pharmaceuticals made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1146 holding.
  • True Wealth Design first reported a position in Vanda Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.